Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 19(23): 6740-4, 2009 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-19836949

RESUMO

In search for specific drugs against steroid-dependent cancers we have developed a novel set of potent inhibitors of steroidogenic human 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD 1). The X-ray structure of 17beta-HSD 1 in complex with estradiol served as basis for the design of the inhibitors. 2-Substituted estrone and D-homo-estrone derivatives were synthesized and tested for 17beta-HSD 1 inhibition. The best 17beta-HSD 1 inhibitor, 2-phenethyl-D-homo-estrone, revealed an IC(50) of 15 nM in vitro. The inhibitory potency of compounds is comparable or better to that of previously described inhibitors. An interaction within the cofactor binding site is not necessary to obtain this high binding affinity for substances developed.


Assuntos
17-Hidroxiesteroide Desidrogenases/antagonistas & inibidores , Desenho de Fármacos , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Estrona/síntese química , Estrona/farmacologia , Cristalografia por Raios X , Inibidores Enzimáticos/química , Estrona/análogos & derivados , Humanos , Modelos Moleculares , Estrutura Molecular , Estereoisomerismo , Relação Estrutura-Atividade
2.
Mol Cell Endocrinol ; 248(1-2): 218-24, 2006 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-16406285

RESUMO

In search for new inhibitors of human 17beta-hydroxysteroid dehydrogenase type 1 (h17beta-HSD1) a specific group of steroids with interesting properties including novel compounds was investigated. Several estratriene derivatives with fluorine-substitution in position 17 of the steroidal scaffold were synthesised and tested in vitro towards recombinant h17beta-HSD1, 2, 4, 5 and 7. Moderate, mostly unselective inhibitors of h17beta-HSD1 and h17beta-HSD2 and a selective inhibitor of h17beta-HSD5 were identified. The structure-activity relationship with respect to inhibitory strengths and selectivity of these compounds on five h17beta-HSDs is discussed.


Assuntos
17-Hidroxiesteroide Desidrogenases/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Estrenos/farmacologia , Estrogênios/farmacologia , Flúor/química , 17-Hidroxiesteroide Desidrogenases/química , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Estrenos/síntese química , Estrenos/química , Estrogênios/síntese química , Estrogênios/química , Humanos , Conformação Proteica , Relação Estrutura-Atividade
3.
BMC Biochem ; 6: 28, 2005 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-16359545

RESUMO

BACKGROUND: 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus (17beta-HSDcl) is a member of the short-chain dehydrogenase/reductase (SDR) superfamily. SDR proteins usually function as dimers or tetramers and 17beta-HSDcl is also a homodimer under native conditions. RESULTS: We have investigated here which secondary structure elements are involved in the dimerization of 17beta-HSDcl and examined the importance of dimerization for the enzyme activity. Sequence similarity with trihydroxynaphthalene reductase from Magnaporthe grisea indicated that Arg129 and His111 from the alphaE-helices interact with the Asp121, Glu117 and Asp187 residues from the alphaE and alphaF-helices of the neighbouring subunit. The Arg129Asp and His111Leu mutations both rendered 17beta-HSDcl monomeric, while the mutant 17beta-HSDcl-His111Ala was dimeric. Circular dichroism spectroscopy analysis confirmed the conservation of the secondary structure in both monomers. The three mutant proteins all bound coenzyme, as shown by fluorescence quenching in the presence of NADP+, but both monomers showed no enzymatic activity. CONCLUSION: We have shown by site-directed mutagenesis and structure/function analysis that 17beta-HSDcl dimerization involves the alphaE and alphaF helices of both subunits. Neighbouring subunits are connected through hydrophobic interactions, H-bonds and salt bridges involving amino acid residues His111 and Arg129. Since the substitutions of these two amino acid residues lead to inactive monomers with conserved secondary structure, we suggest dimerization is a prerequisite for catalysis. A detailed understanding of this dimerization could lead to the development of compounds that will specifically prevent dimerization, thereby serving as a new type of inhibitor.


Assuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , Ascomicetos/enzimologia , 17-Hidroxiesteroide Desidrogenases/química , 17-Hidroxiesteroide Desidrogenases/genética , Sequência de Bases , Primers do DNA , Dimerização , Ligação de Hidrogênio , Peso Molecular , Mutação , Estrutura Secundária de Proteína
4.
Eur Biophys J ; 34(2): 97-112, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15452673

RESUMO

Since high-intensity synchrotron radiation is available, "extended X-ray absorption fine structure" spectroscopy (EXAFS) is used for detailed structural analysis of metal ion environments in proteins. However, the information acquired is often insufficient to obtain an unambiguous picture. ENDOR spectroscopy allows the determination of hydrogen positions around a metal ion. However, again the structural information is limited. In the present study, a method is proposed which combines computations with spectroscopic data from EXAFS, EPR, electron nuclear double resonance (ENDOR) and electron spin echo envelope modulation (ESEEM). From EXAFS a first picture of the nearest coordination shell is derived which has to be compatible with EPR data. Computations are used to select sterically possible structures, from which in turn structures with correct H and N positions are selected by ENDOR and ESEEM measurements. Finally, EXAFS spectra are re-calculated and compared with the experimental data. This procedure was successfully applied for structure determination of the Cu(2+) complex of the octapeptide repeat of the human prion protein. The structure of this octarepeat complex is rather similar to a pentapeptide complex which was determined by X-ray structure analysis. However, the tryptophan residue has a different orientation: the axial water is on the other side of the Cu.


Assuntos
Algoritmos , Cobre/análise , Cristalografia/métodos , Espectroscopia de Ressonância de Spin Eletrônica/métodos , Espectroscopia de Ressonância Magnética/métodos , Metaloproteínas/análise , Príons/análise , Espectrometria por Raios X/métodos , Cobre/química , Metaloproteínas/química , Príons/química , Conformação Proteica
5.
Biopolymers ; 73(4): 421-33, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14991659

RESUMO

In the physiological form, the prion protein is a glycoprotein tethered to the cell surface via a C-terminal glycosylphosphatidylinositol anchor, consisting of a largely alpha-helical globular C-terminal domain and an unstructured N-terminal portion. This unstructured part of the protein contains four successive octapeptide repeats, which were shown to bind up to four Cu(2+) ions in a cooperative manner. To mimic the location of the protein on the cell membrane and to analyze possible structuring effects of the lipid/water interface, the conformational preferences of a single octapeptide repeat and its tetrameric form, as well of the fragment 92-113, proposed as an additional copper binding site, were comparatively analyzed in aqueous and dodecylphosphocholine micellar solution as a membrane mimetic. While for the downstream fragment 92-113 no conformational effects were detectable in the presence of DPC micelles by CD and NMR, both the single octapeptide repeat and, in an even more pronounced manner, its tetrameric form are restricted into well-defined conformations. Because of the repetitive character of the rigid structural subdomain in the tetrarepeat molecule, the spatial arrangement of these identical motifs could not be resolved by NMR analysis. However, the polyvalent nature of the repetitive subunits leads to a remarkably enhanced interaction with the micelles, which is not detectably affected by copper complexation. These results strongly suggest interactions of the cellular form of PrP (PrP(c)) N-terminal tail with the cell membrane surface at least in the octapeptide repeat region with preorganization of these sequence portions for copper complexation. There are sufficient experimental facts known that support a physiological role of copper complexation by the octapeptide repeat region of PrP(c) such as a copper-buffering role of the PrP(c) protein on the extracellular surface.


Assuntos
Micelas , Fosforilcolina/análogos & derivados , Proteínas PrPC/química , Proteínas PrPC/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Dicroísmo Circular , Cobre/metabolismo , Espectroscopia de Ressonância de Spin Eletrônica , Humanos , Metabolismo dos Lipídeos , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Fosforilcolina/metabolismo , Ligação Proteica , Conformação Proteica , Estrutura Terciária de Proteína , Sequências Repetitivas de Aminoácidos , Dodecilsulfato de Sódio/metabolismo , Soluções , Espectrometria de Fluorescência , Água/química
6.
J Pept Sci ; 9(4): 203-11, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12725241

RESUMO

The Y362K mutation in the neck domain of conventional kinesin from Neurospora crassa provokes a significant reduction of the rate of movement along microtubules. Since the alpha-helical coiled-coil structure of the neck region is implicated in the mechanism of the processive movement of kinesins, a series of peptides related to the heptad region 338-379 of the wild-type and the variant fungal kinesinswere synthesized as monomers and as N-terminal disulfide dimers, crosslinked to favour self-association into coiled-coil structures entropically. A comparison of the dichroic properties of the peptides and the effects of trifluoroethanol and peptide concentration clearly confirmed the strong implication of the single point mutation in destabilizing the intrinsic propensity of the peptides to fold into the supercoiled conformation. That there is a correlation between the stability of the coiled-coil and rate of movement of the kinesin is confirmed.


Assuntos
Cinesinas/química , Fragmentos de Peptídeos/química , Sequência de Aminoácidos , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Cinesinas/genética , Proteínas Motores Moleculares/química , Movimento , Mutação de Sentido Incorreto , Fragmentos de Peptídeos/síntese química , Conformação Proteica
7.
Biol Chem ; 384(3): 395-402, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12715890

RESUMO

The ubiquitous calpains, mu- and m-calpain, have been implicated in essential physiological processes and various pathologies. Cell-permeable specific inhibitors are important tools to elucidate the roles of calpains in cultivated cells and animal models. The synthetic N-acetylated 27-mer peptide derived from exon B of the inhibitory domain 1 of human calpastatin (CP1B) is unique as a potent and highly selective reversible calpain inhibitor, but is poorly cell-permeant. By addition of N-terminal cysteine residues we have generated a disulfide-conjugated CP1B with the cell-penetrating 16-mer peptide penetratin derived from the third helix of the Antennapedia homeodomain protein. The inhibitory potency and selectivity of CP1B for calpain versus cathepsin B and L, caspase 3 and the proteasome was not affected by the conjugation with penetratin. The conjugate was shown to efficiently penetrate into living LCLC 103H cells, since it prevents ionomycin-induced calpain activation at 200-fold lower concentration than the non-conjugated inhibitor and is able to reduce calpain-triggered apoptosis of these cells. Penetratin-conjugated CP1B seems to be a promising alternative to the widely used cell-permeable peptide aldehydes (e.g. calpain inhibitor 1) which inhibit the lysosomal cathepsins and partially the proteasome as well or even better than the calpains.


Assuntos
Proteínas de Ligação ao Cálcio/farmacologia , Calpaína/antagonistas & inibidores , Proteínas de Transporte/farmacologia , Inibidores de Cisteína Proteinase/farmacologia , Éxons , Fragmentos de Peptídeos/farmacologia , Apoptose/efeitos dos fármacos , Proteínas de Ligação ao Cálcio/química , Proteínas de Transporte/química , Catepsinas/antagonistas & inibidores , Linhagem Celular , Permeabilidade da Membrana Celular , Peptídeos Penetradores de Células , Inibidores de Cisteína Proteinase/química , Eritrócitos/enzimologia , Humanos , Ionomicina/farmacologia , Fragmentos de Peptídeos/química
8.
EMBO J ; 22(3): 450-8, 2003 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-12554646

RESUMO

The neck domain of fungal conventional kinesins displays characteristic properties which are reflected in a specific sequence pattern. The exchange of the strictly conserved Tyr 362, not present in animals, into Lys, Cys or Phe leads to a failure to dimerize. The destabilizing effect is confirmed by a lower coiled-coil propensity of mutant peptides. Whereas the Phe substitution has only a structural effect, the Lys and Cys replacements lead to dramatic kinetic changes. The steady state ATPase is 4- to 7-fold accelerated, which may be due to a faster microtubule-stimulated ADP release rate. These data suggest that an inhibitory effect of the fungal neck domain on the motor core is mediated by direct interaction of the aromatic ring of Tyr 362 with the head, whereas the OH group is essential for dimerization. This is the first demonstration of a direct influence of the kinesin neck region in regulation of the catalytic activity.


Assuntos
Proteínas Fúngicas/química , Cinesinas/química , Cinesinas/metabolismo , Tirosina/metabolismo , Adenosina Trifosfatases/metabolismo , Trifosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Animais , Domínio Catalítico , Dimerização , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Cinesinas/genética , Microtúbulos/metabolismo , Modelos Biológicos , Modelos Moleculares , Proteínas Motores Moleculares/química , Proteínas Motores Moleculares/genética , Proteínas Motores Moleculares/metabolismo , Dados de Sequência Molecular , Neurospora crassa/química , Neurospora crassa/genética , Neurospora crassa/metabolismo , Peptídeos/genética , Peptídeos/metabolismo , Mutação Puntual , Ligação Proteica , Conformação Proteica , Alinhamento de Sequência
9.
Biol Chem ; 383(5): 849-52, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12108551

RESUMO

Besides its physiological role in lysosomal protein breakdown, extralysosomal cathepsin B has recently been implicated in apoptotic cell death. Highly specific irreversible cathepsin B inhibitors that are readily cell-permeant should be useful tools to elucidate the effects of cathepsin B in the cytosol. We have covalently functionalised the poorly cell-permeant epoxysuccinyl-based cathepsin B inhibitor [R-Gly-Gly-Leu-(2S,3S)-tEps-Leu-Pro-OH; R=OMe] with the C-terminal heptapeptide segment of penetratin (R=epsilonAhx-Arg-Arg-Nle-Lys-Trp-Lys-Lys-NH2). The high inhibitory potency and selectivity for cathepsin B versus cathepsin L of the parent compound was not affected by the conjugation with the penetratin heptapeptide. The conjugate was shown to efficiently penetrate into MCF-7 cells as an active inhibitor, thereby circumventing an intracellular activation step that is required by other inhibitors, such as the prodrug-like epoxysuccinyl peptides E64d and CA074Me.


Assuntos
Proteínas de Transporte/farmacocinética , Catepsina B/antagonistas & inibidores , Catepsinas/antagonistas & inibidores , Inibidores de Cisteína Proteinase/farmacocinética , Oligopeptídeos/farmacocinética , Marcadores de Afinidade/síntese química , Marcadores de Afinidade/química , Sequência de Aminoácidos , Proteínas de Transporte/química , Proteínas de Transporte/farmacologia , Catepsina B/metabolismo , Catepsina L , Permeabilidade da Membrana Celular , Peptídeos Penetradores de Células , Cisteína Endopeptidases , Inibidores de Cisteína Proteinase/química , Inibidores de Cisteína Proteinase/farmacologia , Humanos , Cinética , Neoplasias Mamárias Experimentais/enzimologia , Dados de Sequência Molecular , Oligopeptídeos/síntese química , Oligopeptídeos/farmacologia , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/farmacocinética , Fragmentos de Peptídeos/farmacologia , Relação Estrutura-Atividade , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...